New Novotech Report on Metastatic Breast Cancer Identifies 1,000 Clinical Trials Globally Since 2018

Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, released the latest 2023 global clinical trial landscape report on Metastatic Breast Cancer.